The Optimal Application of Prostate-Specific Antigen (PSA) Velocity to Predict High-Risk Disease.
Loeb
Stacy
S
Department of Urology (SL, AK, PL, HBC), The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, Baltimore, Maryland, and the National Institute on Aging (NIA), National Institutes of Health (NIH), Clinical Research Branch (LF, EJM), Baltimore, Maryland.
Kettermann
Anna
A
Ferrucci
Luigi
L
Landis
Patricia
P
Metter
E Jeffrey
EJ
Carter
Ballentine H
BH